Point-of-care blood device for fast and reliable prediction of drug response in non- small-cell lung carcinoma patients from blood samples

Project Information

LungCARD

Grant agreement ID: 315586

Project closed

Start date 7 February 2013

End date 6 February 2015

Funded under

• Specific Programme "Capacities": Research for the benefit of SMEs

Total cost € 1 479 574,80

EU contribution € 1 056 000,00

Coordinated by

STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA
Portugal